As described by Sarah Zhang in The Atlantic, applying biotechnology to tackle cat allergies is not a new feat. From immunity transfer using egg-yolk coating on Purina’s cat food to cat vaccines that reduce shedding of Fel d 1, the goal of a true hypoallergenic cat remains on the industry’s radar. Is CRISPR genetic therapy next on the list?